Investors
CORPORATE PRESENTATION
Please wait while flipbook is loading. For more related info, FAQs and issues please refer to DearFlip WordPress Flipbook Plugin Help documentation.
Metals Investor Forum Corporate Presentation
Please wait while flipbook is loading. For more related info, FAQs and issues please refer to DearFlip WordPress Flipbook Plugin Help documentation.
SHARE STRUCTURE
As of November 30, 2021
|
Market Capitalization (@ $0.21)
|
$17,020,293
|
|
Shares Issued and Outstanding
|
81,049,015
|
|
Stock Options
|
4,008,750
|
|
Warrants*
|
14,803,000
|
|
Fully Diluted Shares
|
99,860,765
|
|
Significant Shareholders
|
Eric Sprott: 13.57%
Sabre Gold Mines Corp: 17.89% |
WARRANTS
|
19-Nov-22
|
5,600,000
|
$0.15
|
|
19-Nov-22
|
690,000
|
$0.10
|
|
10-May-23
|
8,225,000
|
$0.20
|
|
10-May-23
|
288,000
|
$0.16
|
STOCK INFORMATION
| Exchange: CSX | Symbol: CTOC |
| Last Price: | Volume: |
| Bid Price: | 52 Week High: |
| Ask Price: | 52 Week Low: |
VIDEO
C2C Gold Presents at OTC Virtual Investor Conference, October 2021
Newfoundland Gold Virtual Investors Day 2 - Keynote: Shawn Ryan
Newfoundland Gold Virtual Investors Day 2 - Panel: Chris Healey, Janet Lee-Sheriff & Craig Roberts
SPROTT MONEY: Gold and Silver Ready for Summer - Weekly Wrap Up 5.28.21
WEBINAR WITH JANET LEE-SHERIFF & SHAWN RYAN
Newfoundland Gold Virtual Investors Day 3 - Keynote: Richard Goldfarb
MEDIA
June 7, 2021
Newfoundland’s Area Gold Play: A 21st Century Klondike Gold Rush Analog?
May 11, 2021
The Globe and Mail: Like it or not, natural resources are still the only way forward for Newfoundland
December 6, 2020
A low-carbon future means a big demand for key minerals. Can N.L.’s mines cash in?
FINANCIALS
|
Annual Financial Statement 2021
|
|
|
Q3 Financial Statement
|
|
|
Q3 MD & A
|
|
|
Q2 Financial Statement
|
|
|
Q2 MD & A
|
|
|
Q1 Financial Statement
|
|
|
Q1 MD & A
|
|
Annual Financial Statement 2020
|
|
|
MD & A
|
|
|
Q3 Financial Statement
|
|
|
Q3 MD & A
|
|
|
Q2 Financial Statement
|
|
|
Q2 MD & A
|
|
|
Q1 Financial Statement
|
|
|
Q1 MD & A
|
|
Annual Financial Statement 2019
|
|
|
MD & A
|
|
|
Q3 Financial Statement
|
|
|
Q3 MD & A
|
|
|
Q2 Financial Statement
|
|
|
Q2 MD & A
|
|
|
Q1 Financial Statement
|
|
|
Q1 MD & A
|
|
Annual Financial Statement 2018
|
|
|
MD & A
|
|
|
Q3 Financial Statement
|
|
|
Q3 MD & A
|
|
|
Q2 Financial Statement
|
|
|
Q2 MD & A
|
|
|
Q1 Financial Statement
|
|
|
Q1 MD & A
|
|
Annual Financial Statement 2017
|
|
|
MD & A
|
|
|
Q3 Financial Statement
|
|
|
Q3 MD & A
|
|
|
Q2 Financial Statement
|
|
|
Q2 MD & A
|
|
|
Q1 Financial Statement
|
|
|
Q1 MD & A
|
|
Annual Financial Statement 2016
|
|
|
MD & A
|
|
|
Q3 Financial Statement
|
|
|
Q3 MD & A
|
|
|
Q2 Financial Statement
|
|
|
Q2 MD & A
|
|
|
Q1 Financial Statement
|
|
|
Q1 MD & A
|
